Valute / HROW
HROW: Harrow Inc
39.00
USD
0.01
(0.03%)
Il tasso di cambio HROW ha avuto una variazione del 0.03% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 38.33 e ad un massimo di 39.70.
Segui le dinamiche di Harrow Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
HROW News
- Harrow appoints Andrew R. Boll as president and names Randall E. Pollard chief accounting officer
- Harrow Baby Bonds Yield Review (NASDAQ:HROW)
- Surging Earnings Estimates Signal Upside for Harrow (HROW) Stock
- Best Momentum Stock to Buy for August 15th
- Wall Street Analysts Think Harrow (HROW) Could Surge 53.24%: Read This Before Placing a Bet
- Harrow Stock's Ambitious Guidance Puts It In The Proving Ground (NASDAQ:HROW)
- Harrow Stock Eyes Relative Strength Rating Upgrade
- Harrow: Exciting Times In Store (NASDAQ:HROW)
- H.C. Wainwright raises Harrow Health stock price target on VEVYE growth
- Harrow, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:HROW)
- Harrow, Inc. (HROW) Q2 2025 Earnings Call Transcript
- Harrow Health Q2 2025 slides: Mixed results amid strategic portfolio expansion
- Harrow Health earnings beat by $0.23, revenue fell short of estimates
- Barrick Gold, Roivant Sciences, Owens & Minor to report earnings Monday
- Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Undercovered Dozen: Christian Dior, Coca-Cola, Trinity Capital, Amgen And More
- Harrow Health stock outlook strong as Cantor reiterates Overweight rating
- H.C. Wainwright reiterates Buy rating on Harrow Health stock at $60 target
- Harrow acquires exclusive US rights to Samsung Bioepis eye drugs
- Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar?
- Harrow's Internal $100 Price Target Is Ambitious, But Bloomberg Data Backs It Up (HROW)
- This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Harrow (NASDAQ:HROW), Janux Therapeutics (NASDAQ:JANX)
- Cantor Fitzgerald initiates Harrow Health stock with Overweight rating
- Harrow: Immense Upside Potential (NASDAQ:HROW)
Intervallo Giornaliero
38.33
39.70
Intervallo Annuale
20.85
59.23
- Chiusura Precedente
- 38.99
- Apertura
- 39.44
- Bid
- 39.00
- Ask
- 39.30
- Minimo
- 38.33
- Massimo
- 39.70
- Volume
- 928
- Variazione giornaliera
- 0.03%
- Variazione Mensile
- 25.60%
- Variazione Semestrale
- 39.73%
- Variazione Annuale
- -3.42%
31 agosto, domenica